Prof. Giorgi Pkhakadze, MD, MPH, PhD
Molecular Tumor Boards Show Promise in Bridging Precision Oncology’s Access Gap
A meta-analysis in PLOS Medicine shows that molecular tumor boards—multidisciplinary teams interpreting genomic data—improve precision oncology outcomes. But resource constraints…
Engineered T Cells Show Promise in Hard-to-Treat Children’s Brain Tumors
A phase 1 trial published in Nature Medicine demonstrates that engineered T cells targeting multiple tumor antigens are well tolerated…
GLP-1 medications reduce deaths and amputations in type 2 diabetes with peripheral artery disease
New research published in the Journal of the American Heart Association shows GLP-1 receptor agonist medications reduce deaths, amputations, and…
Psychedelic Therapies at the Threshold: Why Rigorous Surveillance Must Precede Market Access
As psychedelic therapies approach FDA approval, medical journals and regulators must establish rigorous post-market surveillance frameworks to distinguish genuine therapeutic…
UK Health Security Agency Publishes Framework for Evidence-Based Public Health Evaluation
The United Kingdom Health Security Agency has released a comprehensive evaluation strategy establishing systematic assessment of public health interventions across…
WHO Africa Reports Progress on Electronic Disease Surveillance in May 2026 Bulletin
WHO AFRO released its May 2026 electronic surveillance bulletin, documenting eSURV and integrated surveillance system performance across 47 African member…
Trump Administration Derails Alcohol Research as Public Health Crisis Deepens
A STAT investigation reveals the Trump administration has downplayed alcohol's health risks and actively disrupted federal research and prevention efforts,…
Why Are We Losing Americans to Measles? Pennsylvania’s Third Death Exposes Vaccination Infrastructure Collapse
Pennsylvania's third measles-related death signals institutional failure in vaccination infrastructure and public health communication, not inevitable disease spread. Preventing further…